American Journal of Microbiological Research
ISSN (Print): 2328-4129 ISSN (Online): 2328-4137 Website: Editor-in-chief: Apply for this position
Open Access
Journal Browser
American Journal of Microbiological Research. 2015, 3(1), 1-7
DOI: 10.12691/ajmr-3-1-1
Open AccessArticle

Effect of Some Non steroidal Anti-Inflammatory Drugs on Growth, Adherence and Mature Biofilms of Candida spp.

Ahmad Ashraf1, Fatma Yousri1, Nora Taha1, Omar Abd El-Waly2, Abd El-Kareem Ramadan2, Esraa Ismail2, Reham Hamada1, Mohamed Khalaf1, Mohamed Refaee1, Sameh Ali3, Abobakr Madyn4 and Rehab Mahmoud Abd El-Baky5,

1Undergraduate student, faculty of pharmacy, Minia university

2Undergraduate student, Faculty of science, Minia university

3Demonstrator, Department of Microbiology, Faculty of Pharmacy, Minia university

4A researcher, Department of Microbiology, Faculty of Pharmacy, Minia university

5Lecturer of Microbiology, Department of Microbiology, Faculty of Pharmacy, Minia university

Pub. Date: January 05, 2015

Cite this paper:
Ahmad Ashraf, Fatma Yousri, Nora Taha, Omar Abd El-Waly, Abd El-Kareem Ramadan, Esraa Ismail, Reham Hamada, Mohamed Khalaf, Mohamed Refaee, Sameh Ali, Abobakr Madyn and Rehab Mahmoud Abd El-Baky. Effect of Some Non steroidal Anti-Inflammatory Drugs on Growth, Adherence and Mature Biofilms of Candida spp.. American Journal of Microbiological Research. 2015; 3(1):1-7. doi: 10.12691/ajmr-3-1-1


Candida spp. are the most common cause of fungal diseases and the fourth commonest cause of nosocomial invasive infections which are considered in many cases as life threatening. Among Candida spp., C. albicans is the most common cause of many fungal diseases, but non-albicans spp. infections are in increase. Non-steroidal anti-inflammatory drugs have previously been shown to have antifungal activity. In this study we determine the antifungal activity of the tested NSAIDs using agar well diffusion method, their effect on the dimorphic transition of C. albicans by testing their ability to form germ tube in the presence of human serum. Determining the effect of NSAIDs on the adherence to plastic surfaces and on the mature biofilms formed by the tested Candida spp.. The results indicated that Sodium Diclofenac showed lower MIC against C. albicans and C. glabrata while Ibuprofen had lower MIC against C. krusei. upon examining the effect of Diclofenac sodium, Ibuprofen and ketoprofen on biofilm formed on polyurethane segments by Scanning electron microscope (SEM), a damage to membranes of the tested species was observed. Sodium Diclofenac showed the highest inhibitory effect on the adherence (51.1-76.9% at MIC and 56.6-83.3% at 2XMIC) of C. albicans and C. glabrata but Ibuprofen showed a higher inhibitory effect against the adherence of C. krusei. For mature biofilms, the highest disruptive effect on mature biofilms formed by all tested Candida Spp. (37.72-59.29% at MIC and 42.68-63.06% at 2XMIC) was observed by Diclofenac sodium. Sodium Diclofenac inhibited dimorphic transition of C. albicans but a decrease in germ tube formation was shown by others. In conclusion, the tested drugs showed antifungal, anti-adherent and anti-biofilm activity that make them useful in the treatment of fungal infection and the prevention of biofilm formation on the surface of medical devices.

Ketoprofen Ibuprofen Diclofenac sodium biofilm Candida Dimorphic transition

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


Figure of 5


[1]  Douglas JL, Cobbs CG. Prosthetic valve endocarditis. In: Kaye D, Ed. Infective endocarditis. 2d ed. New York: Raven Press 1992; 375-96.
[2]  Tunney MM, Patrick S, Curran MD, et al. Detection of prosthetic joint biofilm infection using immunological and molecular techniques. Methods Enzymol 1999; 310: 566-76.
[3]  Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993; 168 (2): 400-7.
[4]  Ramage G, Martínez JP, López-Ribot JL. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 2006; 6 (7): 979-86.
[5]  Seneviratne CJ, Jin L, Samaranayake LP. Biofilm lifestyle of Candida: a mini review. Oral Dis 2008, 14 (7): 582-90.
[6]  LaFleur M, Kumamoto CA and Lewis K. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 2006, 50: 3839-46.
[7]  Characklis W G, and Wilderer P A. Structure and function of biofilms. Wiley, Chichester, United Kingdom. 1989.
[8]  Costerton, J. W., K. J. Cheng, G. G. Geesey, T. I. Ladd, J. C. Nickel, M. Dasgupta, and T. J. Marrie. Bacterial biofilms in nature and disease. Annu. Rev. Microbiol. 1987, 41: 435-464.
[9]  Dougherty S H. Pathobiology of infection in prosthetic devices. Rev. Infect. Dis. 1988, 10: 1102-1117.
[10]  Elliott T S J. Intravascular device infections. J. Med. Microbiol. 1988, 27: 161-167.
[11]  Goldmann D A, and Pier G B. Pathogenesis of infections related to intravascular catheterization. Clin. Microbiol. Rev. 1993, 6: 176-192.
[12]  Gristina AG. Biomaterial centered infection: microbial adhesion versus tissue integration. Science 1987, 237: 1588-1595.
[13]  Melo L F, Bott T R, Fletcher M, and Capdeville B. Biofilms-science and technology. Kluwer Academic Publishers, Dordrecht, The Netherlands 1992.
[14]  Brown M R W, and Gilbert P. Sensitivity of biofilms to antimicrobial agents. J Appl Bacteriol Symp 1993, 74:87S-97S.
[15]  Cox G M, and Perfect J R. Fungal infections. Curr Opin Infect Dis 1993, 6: 422-426.
[16]  Wey S B, Mori M, and Pfaller M A. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 1988, 148: 2642-2645.
[17]  Maki D G. Pathogenesis, prevention and management of infections due to intravascular devices used for infusion therapy, 1989, 161-177. In A. L. Bisno and F. A. Waldvogel (ed.), Infections associated with indwelling medical devices. American Society for Microbiology, Washington, D.C.
[18]  Odds FC. Candida and candidosis, 2nd ed. Bailliere Tindall, London. 1988
[19]  Alem MA, Douglas LJ. Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob Agents Chemother 2004, 48: 41-7.
[20]  Dannhardt G, Kiefer W. Cyclooxygenase inhibitors-current status and future prospects. Eur J Med Chem 2001, 36: 109-26.
[21]  Alem MA, Douglas LJ. Prostaglandin production during growth of Candida albicans biofilms. J Med Microbiol 2005, 54: 1001-5.
[22]  Erb-Downward JR, Noverr MC. Characterization of prostaglandin E2 production by Candida albicans. Infect Immun 2007, 75: 3498-505.
[23]  Pina-Vaz C, Rodrigues AG, Costa-de-Oliveira S, Ricardo E and Ma°rdh P. Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry. J Antimicrob Chemother 2005 56: 678-685.
[24]  Benson HC. Microbiological Application: Laboratory Manual in General Microbiology, 11th ed., McGram-Hill Higher Education, Sanfrancisco, 2002, pp.168.
[25]  Christensen GD, Simpson WA, Younger J A, Baddour L M, Barrett F F, Melton D M, et al. Adherence of coagulase negative Staphylococci to plastic tissue cultures: a quantitative model for the adherence of Staphylococci to medical devices. J Clin Microbiol 1985, 22: 996-1006.
[26]  O'Toole AG and Kolter R. Initiation of biofilm formation in Pseudomonas fluorescence WCS365 proceeds via multiple, convergent signaling pathways: a genetic analysis. Molecular microbiology 1998, 28: 449.
[27]  Bennet JV, Brodie JL, Benner JL, Kirby WMM. “Simplified accurate method for antibiotic assay of clinical specimens. Applied Microbiology 1966, 14: 2170-2177.
[28]  Negero Gemeda, Kelbessa Urga, Ashenif Tadele, Hirut Lemma, Daniel Melaku, Kissi Mudie. “Antimicrobial Activity of Topical Formulation Containing Eugenia caryophyllata L. (Krunfud) and Myritus communis L. (Ades) Essential Oils on Selected Skin Disease Causing Microorganisms.” Ethiop. J. Health Sci. 2008, 18(3): 101-107.
[29]  Esimone C O, Adiukwu M U, Okonta J M, “Preliminary Antimicrobial Screening of the Ethanolic Extract from the Lichen Usnea subfloridans L,”. IJPRD 1998, 3: 99-102.
[30]  Liu H, Kohler J, Fink GR. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science (New York, NY) 1994, 266: 1723-6.
[31]  Xiaogang L, Zhun Y and Jianping X. Quantitative variation of biofilms among strains in natural populations of Candida albicans. Microbiology 2003, 149: 353-362.
[32]  Soboh F, Khoury AE, Zamboni AC, Davidson D, Mittelman MW. Effects of ciprofloxacin and protamine sulfate combinations against catheter-associated Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother 1995, 39: 1281-1286.
[33]  Jacqueline M, Achkar, Bettina C. Candidal Infections of the Genitourinary tract. Clin. Microbiol. Rev. 2010, 23(2):253-72.
[34]  Mohandas V, Ballal M. Distribution of Candida Species in Different Clinical Samples and Their Virulence: Biofilm Formation, Proteinase and Phospholipase Production: A Study on Hospitalized Patients in Southern India. J. Glob. Infect. Dis. 2011, 3 (1): 4-8.
[35]  Seneviratne CJ, Jin L, Samaranayeke LP. Biofilm lifestyle of Candida: A mini review. Oral. Dis. 2008, 14: 582-590.
[36]  Aparna MS, Yadav S. Biofilms: Microbes and Disease. The Braz J. Infect. Dis. 2008, 12: 526-530.
[37]  Cederlund H, Màrdh P-A. Antibacterial activities of N-acetylcysteine and some non steroidal anti-inflammatory druga. J. Antimicrob chemother 1993 32: 903-904.
[38]  Sanyal AK, Roy D, Chowdhury B, Banerjee AB. Ibuprofen, a unique anti-inflammatory compound with antifungal a activity against dermatophytes. Lett Appl Microbial 1993, 109-111.
[39]  Scott E M, Tariq VN, McCrory R M. Demonsteration of synergy with fluconazole and either ibuprofen, sodium salicylate or propylparaben against C. albicans in-vitro. Antimicrob. Agents Chemother 1995, 39: 2610-2614.
[40]  Alem MA, Douglas LJ. Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob Agents Chemother 2004, 48:41-7.
[41]  Ghalehnoo Z R, Rashki A, Najimi M, Dominguez A. The role of Sodium Diclofenacin the dimorphic transition in Candida albicans Microbial Pathogenesis 2010, 48: 110-115
[42]  Bink, A, Kucharíková S, Neirinck B, Vleugels J, Dijck P V, Cammue B P. A. and Thevissen K. The Non-steroidal Anti-inflammatory Drug Diclofenac Potentiates the In Vivo Activity of Caspofungin Against Candida albicans Biofilms JID 2012:206.
[43]  Alem MA, Douglas LJ. Prostaglandin production during growth of Candida albicans biofilms. J Med Microbiol 2005, 54:1001-5.
[44]  Pina-Vaz C, Sansonetty F, Rodrigues A et al. Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species. J Med Microbiol 2000, 49: 831-40.
[45]  Chowdhury B, Mukhopadhyay S. Ketoprofen, a non-steroidal, anti-inflammatory drug, has antimicrobial activity against dermatophytes Medical Science Research. 1997, 25: 109-110.
[46]   Samaranayake Y H, Samaranayake LP. Candida krusei: biology, epidemiology, Pathogenicity and clinical manifestations of an emerging pathogen. J. Med. Microbiol. 1994, 41. 295-310.
[47]  Abdelmegeed E and Shaaban M I, Cyclooxygenase inhibitors reduce biofilm formation and yeast-hypha conversion of fluconazole resistant Candida albicans. J microbiol 2013, 51: 598-604.